+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe

Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe

International Journal of Pediatric Otorhinolaryngology 116: 147-152

Recurrent respiratory papillomatosis (RRP) caused by human papillomavirus (HPV) is preventable through vaccination. This study was motivated by the recent thrust of the Zimbabwean government to reduce incidence of HPV related cervical cancer in Zimbabwe through vaccination against HPV. We therefore set out to type HPV genotypes causing RRP in Zimbabwe. We also describe for the first time, the demographics of Zimbabwean RRP patients, the characteristics of patients with different HPV types and possible risk factors of HPV infection in our setting. We conducted a prospective, hospital based study were patients were recruited from two national otorhinolaryngology hospitals in Zimbabwe. All patients diagnosed with RRP during a twenty four month period were included in the study. A questionnaire was administered per patient to collect both demographic and clinical variables. HPV DNA was extracted from formalin fixed paraffin embedded laryngeal tissue. The extracted HPV DNA was amplified using polymerase chain reaction and next generation sequencing was used to genotype the HPV types. A total of 52 patients all aged 14 years and under were recruited into the study. Only Juvenile onset RRP cases were observed over the two year period and 64% of the patients were HPV positive. HPV types 6 and 11 were the dominant types observed constituting 85% of all HPV types. The remaining 15% constituted of HPV 16 and HPV 18. 27% of the patients had coinfection with at least two different HPV types. There were no statistically significant differences between the characteristics of HPV positive and HPV negative patients. No statistically significant risk factors were observed. HPV types 6 and 11 were the predominant genotypes causing RRP in Zimbabwe. Thus the use of quadrivalent or even nonavalent HPV vaccines may play an important role in the prevention and management of RRP in Zimbabwe.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066011310

Download citation: RISBibTeXText

PMID: 30554686

DOI: 10.1016/j.ijporl.2018.10.036

Related references

Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in southern Africa. Epidemiology and Infection 140(6): 1095-1101, 2012

Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 126(9): 1119-1123, 2000

Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 83: 94-98, 2016

Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil. Infection Genetics and Evolution 16: 282-289, 2013

Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11. Journal of Infectious Diseases 189(5): 871-879, 2004

UK needs vaccine to protect against HPV types causing recurrent respiratory papillomatosis. Bmj 343: D6672, 2011

Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head and Neck 37(11): 1625-1632, 2015

Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology 4(1): 68-72, 2001

Detection of human papillomavirus in the upper respiratory tract in children without recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(12): 974-977, 2012

Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Archives of Otolaryngology--Head & Neck Surgery 119(5): 554-557, 1993

Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Annals of Otology Rhinology and Laryngology 101(5): 408-412, 1992

Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head and Neck 35(2): 229-234, 2013

Divergent human papillomavirus associated with recurrent respiratory papillomatosis with lung involvement. Genome Announcements 1(4):, 2013

Human papillomavirus infection in recurrent upper respiratory tract papillomatosis. Archiv fuer Geschwulstforschung 60(6): 429-434, 1990

Detection and cloning of human papillomavirus DNA associated with recurrent respiratory papillomatosis in Thailand. Japanese Journal Of Cancer Research. 85(7): 699-703, 1994